Vitamin D is a New Promising Inhibitor to the Main Protease (Mpro) of COVID-19 by Molecular Docking
Ghassab M. Al-Mazaideh, Mohammed H. Shalayel, Farhan K. Al-Swailmi & Saleem H. Aladaileh · Journal of Pharmaceutical Research International · 2021
In this study, vitamin D has shown greater efficacy of binding with Mpro of COVID-19 compared to the recently recommended drugs. The docking study was simulated to streamline interaction effects of Vitamin D, Remdesivir, Chloroquine, Hydroxychloroquine, Aspirin, and Azithromycin...
Open access
Research Article
10.9734/jpri/2021/v33i29B31603